Suppr超能文献

糖皮质激素通过受体介导诱导人肾小球上皮细胞(HGEC)产生氨肽酶A(APA)。

Receptor-mediated induction of aminopeptidase A (APA) of human glomerular epithelial cells (HGEC) by glucocorticoids.

作者信息

Stefanovic V, Vlahovic P, Ardaillou N, Ardaillou R

机构信息

INSERM 64, Hôpital Tenon, Paris, France.

出版信息

FEBS Lett. 1991 Dec 9;294(3):171-4. doi: 10.1016/0014-5793(91)80661-l.

Abstract

Membrane-bound peptidases are critical regulators of peptide hormones. We therefore characterized aminopeptidase A (APA) activity in human glomerular epithelial cells (HGEC) and studied the control of its expression. APA, which splits off the N-terminal Asp from angiotensin II (AII), was present at the surface of HGECs (55% of the total enzyme). APA activity was calcium-dependent and was inhibited by amastatin. Treatment of HGECs by dexamethasone (DEX) increased ecto-APA activity in a dose- and time-dependent manner. Maximal increase of APA activity (x 2) occurred after treatment with 0.5 microM DEX for 5 days. HIgher concentrations (1-10 microM) of aldosterone (ALD) stimulated APA activity to a lesser extent (x 1.25). Actinomycin D and cycloheximide prevented and RU 38486, a glucocorticoid receptor antagonist, suppressed the DEX-induced increase in APA activity. These results indicate that AII availability at glomerular receptor sites may be reduced by DEX and suggest a role for glucocorticoids in AII-dependent changes of glomerular filtration rate.

摘要

膜结合肽酶是肽类激素的关键调节因子。因此,我们对人肾小球上皮细胞(HGEC)中的氨肽酶A(APA)活性进行了表征,并研究了其表达的调控。APA可从血管紧张素II(AII)上裂解掉N端的天冬氨酸,它存在于HGEC表面(占总酶的55%)。APA活性依赖于钙,并被氨肽菌素抑制。地塞米松(DEX)处理HGEC可使胞外APA活性呈剂量和时间依赖性增加。用0.5 microM DEX处理5天后,APA活性达到最大增加(增加2倍)。较高浓度(1 - 10 microM)的醛固酮(ALD)对APA活性的刺激程度较小(增加1.25倍)。放线菌素D和环己酰亚胺可阻止,而糖皮质激素受体拮抗剂RU 38486可抑制DEX诱导的APA活性增加。这些结果表明,DEX可能会降低肾小球受体部位的AII可用性,并提示糖皮质激素在AII依赖的肾小球滤过率变化中起作用。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验